# Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis

> **NCT00345137** · PHASE1 · COMPLETED · sponsor: **Regional Hospital Holstebro** · enrollment: 75 (—)

## Conditions studied

- ADPKD
- Glomerulonephritis

## Interventions

- **DRUG:** Ng-monomethyl-L-arginine (drug)

## Key facts

- **NCT ID:** NCT00345137
- **Lead sponsor:** Regional Hospital Holstebro
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 75 (—)
- **Last updated:** 2006-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00345137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00345137, "Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00345137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*